ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,370.33
-0.55%
Dow Jones
39,671.04
-0.51%
Gold vs US Dollar
2,368.41
-0.57%
Brent Oil
81.165
-0.45%
Bitcoin
69,319.35
0.31%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aeterna Zentaris Inc (AEZS)

  7. Aeterna Zentaris Inc (AEZS) News

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AEZS
DateTimeSourceHeadlineSymbolCompany
17/05/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
17/05/202413:00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:AEZSAeterna Zentaris Inc
17/05/202413:00GlobeNewswire Inc.Aeterna Zentaris Announces Details Regarding Transaction with CeaproNASDAQ:AEZSAeterna Zentaris Inc
17/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEZSAeterna Zentaris Inc
17/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEZSAeterna Zentaris Inc
14/05/202423:00GlobeNewswire Inc.Aeterna Zentaris Reports First Quarter 2024 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
01/05/202412:55GlobeNewswire Inc.Aeterna Zentaris Announces Effective Date of Share ConsolidationNASDAQ:AEZSAeterna Zentaris Inc
28/03/202411:55GlobeNewswire Inc.Ceapro Receives Final Court Approval for Merger with Aeterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
28/03/202411:55GlobeNewswire Inc.Ceapro Receives Final Court Approval for Merger with Aeterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
27/03/202412:05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
12/03/202418:10GlobeNewswire Inc.Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsNASDAQ:AEZSAeterna Zentaris Inc
12/03/202418:10GlobeNewswire Inc.Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsNASDAQ:AEZSAeterna Zentaris Inc
26/02/202412:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
26/02/202412:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
15/02/202422:50GlobeNewswire Inc.Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with CeaproNASDAQ:AEZSAeterna Zentaris Inc
15/02/202421:54Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:AEZSAeterna Zentaris Inc
15/02/202414:33Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
22/12/202321:42Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202312:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202312:50GlobeNewswire Inc.Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
09/11/202313:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
09/11/202313:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
09/11/202313:00GlobeNewswire Inc.Aeterna Zentaris Reports Third Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
11/10/202313:00GlobeNewswire Inc.Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO ConferenceNASDAQ:AEZSAeterna Zentaris Inc
05/09/202313:00GlobeNewswire Inc.Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AEZSAeterna Zentaris Inc
09/08/202313:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
09/08/202313:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
09/08/202313:05GlobeNewswire Inc.Aeterna Zentaris Reports Second Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
13/07/202312:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
13/07/202312:30GlobeNewswire Inc.Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate UpdateNASDAQ:AEZSAeterna Zentaris Inc
 Showing the most relevant articles for your search:NASDAQ:AEZS

Your Recent History

ASX
SYM
Symbio
BIT
P1XE41
NLBNPIT1XE41 20241220 320
USOTC
GENPF
Genix Pharmaceuticals (QB)
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved